BioLegend Licenses Single-Cell Analysis Technology from New York Genome Center

Jan 11, 2018

|

NEW YORK (GenomeWeb) – BioLegend has licensed a multidimensional single-cell analysis technology from the New York Genome Center and is collaborating with the center on further research, the two organizations said today.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Test Evaluations

UK Royal Statistical Society is organizing a working group to develop guidelines for assessing COVID-19 tests, the Guardian reports.

Justification for Stricter Standards Sought

The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.

Concerns Over Comment

President Donald Trump's "good genes" comment raises eugenics concerns, CNN reports.

PLOS Papers on Tremor Condition, Medical Plant Populations, Brewing Yeast Transcriptomics

In PLOS this week: genetic analysis of tremor condition, analysis of a West and Central African tree used in traditional medicine, and more.

Menu

BioLegend Licenses Single-Cell Analysis Technology from New York Genome Center

To read the full story....

Breaking News

Cerebral Palsy Genomic Study Points to Rare Damaging Mutations as Disease Contributors

Dozens of Genetic Loci Influence Handedness, GWAS Meta-Analysis Finds

UK Government Unveils New Genomic Healthcare Strategy

Alzheimer's Disease Linked to Epigenetic Changes in Multi-Omic Study

Zymo Research Gets CE-IVD Mark for Sample Collection Devices

Ceres Nanosciences Nabs $243K SBIR Grant to Adapt RNA Capture Tech for Portable Sequencing

The Scan

Test Evaluations

Justification for Stricter Standards Sought

Concerns Over Comment

PLOS Papers on Tremor Condition, Medical Plant Populations, Brewing Yeast Transcriptomics

What's Popular?

Angle Files De Novo FDA Submission for CTC Collection Device in Breast Cancer

Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test

Ionpath Expanding Sales Force, Investing in Informatics Tools Development

Catalog DNA Merges Molecular Biology, Information Theory to Pursue DNA-Based Computing

Zymo Research Gets CE-IVD Mark for Sample Collection Devices

Sponsorships